PROVIDER PROFILE · NPI 1912001520

David MesibovMD

PRACTICEDRS LAHIRI & MESIBOV LLCSee all providers at this practice →

Family PracticeLos Alamos, NMI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

951

Unique beneficiaries

—

Total services

1,510

Distinct HCPCS

Medicare payment

$71K

Peer benchmark

Total Medicare services vs. 617 Family Practice providers in NM — top quintile (cohort median 308).

PRESCRIBING · PART D · 2024

Total Rx claims

1,719

Beneficiaries

—

Total drug cost

$127K

Distinct drugs

Brand share

20.7%

Top prescribed drugs

Oxycodone Hcl136 claims

Levothyroxine Sodium94 claims

Gabapentin85 claims

Rosuvastatin Calcium78 claims

Lorazepam65 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$653

Payment records

By payment type

Food and Beverage$653

REFERRAL NETWORK

Where David Mesibov's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
TRICORE REFERENCE LABORATORIES	148	835
PHC-LOS ALAMOS INC	101	435
Aparimita Lahiri Endocrinology · Los Alamos, NM	23	68
PRESBYTERIAN HEALTHCARE SERVICES	15	52
TAYLOR, HERBERT	14	31
Lori Whitley Dermatology · Los Alamos, NM	12	36
Christopher Hammond Emergency Medicine · El Segundo, CA	11	32
Robert Mcclees Family Practice · Los Alamos, NM	11	21

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history